Arin Bose is Vice President, Process Development at Akero Therapeutics. In this role, Arin is responsible for leading the manufacturing and process development for AKR-001. Arin comes to Akero Therapeutics after his retirement from Pfizer, where he last served as Vice President of External Affairs & Biosimilars Strategy in the Biotherapeutics Pharmaceutical Sciences division. Arin spent over 30 years at Pfizer and during his time there, held numerous technical and leadership positions with increasing responsibility in process development, clinical supply/commercial manufacturing, corporate biotechnology strategy and lobbying for science-based regulations for biologics and vaccines. Arin is also currently an Independent Director of Dyadic International, a global biotechnology company. Arin holds a PhD in Chemical Engineering from Purdue University, an MS in Chemical Engineering from the University of Michigan, Ann Arbor, and a BTech in Chemical Engineering from the Indian Institute of Technology, Kanpur.